ABSTRACT
Nos últimos anos, diretrizes para a comunicação médica de más notícias aos pacientes foram publicadas. Treinamentos para esta tarefa passaram a ser incluídos nos currículos de graduação, especialização e educação médica continuada. O objetivo desta revisão foi avaliar as evidências existentes na literatura sobre a eficácia destes treinamentos. Apenas sete estudos controlados, quatro dos quais randomizados, foram encontrados. Quatro deles indicam melhora dos aprendizes que foram treinados. Estes achados mostram que o treinamento em comunicação de más notícias pode ser eficaz para médicos e estudantes, mas há importantes limitações que impedem conclusões definitivas. Estas limitações são discutidas.
Guidelines for communicating bad news to patients have been published and training programs for this task have been included in graduate and post-graduate medical courses. The aim of this review was to evaluate evidence_ of the efficacy of these trainings in the medical literature. Only seven controlled trials, four of them randomized, were found. Four for them showed improvement in communication skills in the trained apprentices. These findings suggest that training undergraduate and post-graduate doctors in the skills for communicating bad news may be beneficial but there are important limitations to reach a definitive conclusion. These limitations are discussed.
ABSTRACT
O autor discute as limitações enfrentadas pelos centros de onco-hematologia nacionais na condução de pacientes com Leucemia Mielóide Crônica e os problemas relacionados à implementação, custeio e avaliação de resultados dos programas de tratamento para esta enfermidade.
This article discusses the limitations which Brazilian hematology-oncology centers face when conducting treatment programs for Chronic Myeloid Leukemia and the problems concerning their implementation, funding and quality assessment by National Health Organization.
Subject(s)
Humans , Health Planning , Leukemia, Myelogenous, Chronic, BCR-ABL PositiveABSTRACT
Woman, 42 years-old, receiving immunosuppressive therapy for a lymphoma, presented reagudization of Chagas' disease, from its indeterminate phase. Intense inflammatory visceral aggression, due to extensive intracellular proliferation of the Trypanosoma cruzi, was the likely mechanism for acute myocarditis leading to severe right ventricular failure. Antiparasite chemotherapy was effective in the control of visceral involvement and for the remission of cardiac failure. The clinical course in this case is compatible with the hypothesis of early right ventricular damage in Chagas' disease